期刊论文

Safety and efficacy of Danhong Injection combined with Edaravone in the treatment of acute cerebral infarction: A systematic review

中文

中华中医药杂志

1673-1727

2017

32

10

4683-4689

湖南省科技厅重点项目

本校为第一机构

目的:系统评价丹红注射液联合依达拉奉治疗急性脑梗死的疗效和安全性。方法:通过检索中国生物医学文献数据库、中国期刊全文数据库、维普期刊数据库、万方期刊数据库、美国国立医学图书馆数据库从2011年1月至2016年12月的中英文文献,选择符合纳入及排除标准的随机对照试验,对纳入文献进行质量评价,采用RevMan 5.3版软件进行Meta分析。结果:共纳入24个研究,2 266例患者。丹红注射液联合依达拉奉在疗效方面对比单用丹红注射液、依达拉奉及常规治疗有优势,疗效合并效应量(RR=122, 95%CI[1.18, 1.27], P

Objective:To assess the safety and efficacy of Danhong Injection combined with Edaravone Injection for acute cerebral infarction (ACI). Methods: To search CBM, CNKI, VIP, WF, MEDLINE for randomized controlled trials (RCTs) of related articles from January 2011 to November 2016. After assessed the quality of studies included, RevMan 5.3 software was used to analyze data. Results: Twenty-four studies, were included and 2 266 patients were involved. The results showed that the effective rate of Danhong Injection combined with Edaravone for ACI was better than that of control group with statistica...